Polymyalgia rheumatica: strategies for efficient practice and quality assurance

Michael Schirmer, Christian Dejaco, Bhaskar Dasgupta, Eric L. Matteson

Research output: Contribution to journalReview articlepeer-review

7 Scopus citations


Polymyalgia rheumatica (PMR) is the most common inflammatory rheumatic disease in persons over the age of 50 years. There are many diseases which mimic PMR, for which reason a careful diagnostic approach is required. While it is thought to be exquisitely responsive to glucocorticosteroid therapy, many patients respond incompletely and/or develop serious side effects over the protracted disease course. Improved methods for classification and disease assessment together with standardized treatment approaches and outcome assessments can serve to improve the care of patients with this disease.

Original languageEnglish (US)
Pages (from-to)1781-1789
Number of pages9
JournalRheumatology International
Issue number11
StatePublished - Nov 1 2015


  • Classification criteria
  • Diagnosis
  • Outcome
  • Polymyalgia rheumatica
  • Quality measures
  • Treatment

ASJC Scopus subject areas

  • Immunology and Allergy
  • Rheumatology
  • Immunology


Dive into the research topics of 'Polymyalgia rheumatica: strategies for efficient practice and quality assurance'. Together they form a unique fingerprint.

Cite this